[Targeted immunotherapy against interleukin 2 receptors (IL-2R)--an attempt at synthesis].
Sabliński
T
T
Surgical Research Laboratory, Harvard Medical School, Boston, Massachusetts.
Wasik
M A
MA
Tilney
N L
NL
Kupiec-Wegliński
J W
JW
D000818:Animals; D000911:Antibodies, Monoclonal / Q000627:therapeutic use; D001327:Autoimmune Diseases / Q000628:therapy; D007167:Immunotherapy / Q000379:methods*; D007376:Interleukin-2 / Q000737:chemistry / Q000627:therapeutic use*; D015375:Receptors, Interleukin-2 / Q000187:drug effects
D000911:Antibodies, Monoclonal; D007376:Interleukin-2; D015375:Receptors, Interleukin-2
Immunoterapia skierowana przeciw receptorowi dla interleukiny 2 (IL-2R)--próba syntezy.